此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Exercise Training in Pregnancy for Obese Mothers

Exercise Training in Pregnancy. Good for the Mother - Good for the Child?

Observational studies demonstrate that overweight in pregnancy is a risk factor for adverse pregnancy outcomes as fetal macrosomia, prolonged labor, low Apgar score, shoulder dystocia, nerve plexus injuries, increased proportion of instrumental deliveries and perineal ruptures. There is a 2.6 fold risk for gestational diabetes mellitus (fourfold in morbidly obese women) and a recent study has shown that fetuses of obese mothers develop insulin resistance in uterus.

Main aims of this study are to assess if regular exercise in pregnancy among obese women can prevent or influence weight gain; impaired cardiac function in mother and fetus/newborn; impaired vascular function in mother; insulin resistance/sensitivity; body composition in mother and offspring; lumbopelvic pain; urinary and/or fecal incontinence; prolonged labor

研究概览

地位

完全的

条件

详细说明

Women with a self-reported pre-pregnancy BMI of 28 or more will be eligible for our study. Woman are eligible if they are 18 years or older, with a singleton live fetus at an early (week 12-14) ultrasound scan. Exclusion criteria are pregnancy complications with high risk for preterm labour or diseases that could interfere with participation.

Primary outcome measure is weight increase based on weight measured at 14 weeks and immediately before labour. Assessments are done at baseline at 14 (12-18) weeks of pregnancy, and again in week 38, as well as 3 months postpartum. Some measurements are also done at other points in time. The maternal secondary outcome measurements include fasting glucose, glucose tolerance assessed by 2-h, 75 mg per-oral glucose tolerance test, insulin resistance assessed by HOMA-IR, weight, height, body composition estimated by skinfold measurements in pregnancy and by dual energy x-ray absorptiometry postpartum, blood markers, lumbopelvic pain, urin- and fecal incontinence, quality of life, psychological wellbeing, depression, and diet.

研究类型

介入性

注册 (实际的)

91

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Trondheim、挪威、7489
        • Norwegian University of Science and Technology

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

女性

描述

Inclusion Criteria:

  • Pre-pregnancy body mass index of 28 or more
  • 18 years or more
  • singleton live fetus at the routine ultrasound scan

Exclusion Criteria:

  • high risk for preterm labor or diseases that could interfere with participation

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:预防
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
实验性的:Exercise training
Supervised exercise training at the hospital during pregnancy: the women will attend at least 2 weekly sessions consisting of aerobic exercise (walking on treadmills), strength training (for upper body, back, abdomen and legs) as well as pelvic floor muscle exercises. Each session is 60 minutes and lead by a physiotherapist or experienced exercise physiologist. The women will also go through motivational interviewing sessions throughout the intervention period and are encouraged to do home exercise training in addition to the exercise at the hospital
Exercise training at the hospital
其他名称:
  • 训练
无干预:Control
Usual care as provided by the health services in Norway. The investigators will not advice the women to be inactive

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Weight gain during pregnancy
大体时间:From 14 weeks pregnancy to delivery
Measured in kg
From 14 weeks pregnancy to delivery

次要结果测量

结果测量
措施说明
大体时间
Fasting glucose
大体时间:From 14 weeks pregnancy to 38 weeks pregnancy and also at 3 months postpartum
Blood samples to determine the fasting glucose after an overnight fast (>10 hours)
From 14 weeks pregnancy to 38 weeks pregnancy and also at 3 months postpartum
Glucose tolerance
大体时间:From 14 weeks pregnancy to 38 weeks pregnancy and also at 3 months postpartum
2 hour 75 mg per-oral glucose tolerance test. Gestational diabetes is diagnosed as fasting glucose = or > 6.9 mmol/L or 2h concentration = or > 7.8 mmol/L.
From 14 weeks pregnancy to 38 weeks pregnancy and also at 3 months postpartum
Insulin resistance
大体时间:From 14 weeks pregnancy to 38 weeks pregnancy and also at 3 months postpartum
Homeostasis model assessment (HOMA-IR)
From 14 weeks pregnancy to 38 weeks pregnancy and also at 3 months postpartum
Body composition
大体时间:From 14 weeks pregnancy to 38 weeks pregnancy and also at 3 months postpartum
Skinfold measurements, done by an experienced investigator using Harpenden kaliper. At the 3 months postpartum testing, also dual energy x-ray absorptiometry (DEXA scan) will be used.
From 14 weeks pregnancy to 38 weeks pregnancy and also at 3 months postpartum
Blood markers for cardiovascular disease
大体时间:From 14 weeks pregnancy to 38 weeks pregnancy and also at 3 months postpartum
Inflammation markers, cytokines (leptin, resistin, adiponectin, tnf-alfa). Blood will be collected and stored for later analyses.
From 14 weeks pregnancy to 38 weeks pregnancy and also at 3 months postpartum
Lumbopelvic pain
大体时间:From 14 weeks pregnancy to 38 weeks pregnancy and also at 3 months postpartum
Clinical assessment (active straight leg raising, pelvic provocation test), and validated questionnaire.
From 14 weeks pregnancy to 38 weeks pregnancy and also at 3 months postpartum
Urin- and fecal incontinence
大体时间:From 14 weeks pregnancy to 38 weeks pregnancy and also at 3 months postpartum
Pelvic floor muscle function will be assessed by clinical assessment and by 2D and 3D ultrasound. The prevalence and severity of urin- and fecal incontinence will also be assessed by a validated questionnaire
From 14 weeks pregnancy to 38 weeks pregnancy and also at 3 months postpartum
Quality of life
大体时间:From 14 weeks pregnancy to 38 weeks pregnancy and also at 3 months postpartum
Validated questionnaire
From 14 weeks pregnancy to 38 weeks pregnancy and also at 3 months postpartum
Sleep
大体时间:From 14 weeks pregnancy to 38 weeks pregnancy and also at 3 months postpartum
Epworth sleepiness scale
From 14 weeks pregnancy to 38 weeks pregnancy and also at 3 months postpartum
Physical activity
大体时间:From 14 weeks pregnancy to 38 weeks pregnancy and also at 3 months postpartum
Level of physical activity will be assessed by activity registration (armbands) and by validated questionnaires
From 14 weeks pregnancy to 38 weeks pregnancy and also at 3 months postpartum
Diet
大体时间:From 14 weeks pregnancy to 38 weeks pregnancy and also at 3 months postpartum
Validated questionnaire: Norkost
From 14 weeks pregnancy to 38 weeks pregnancy and also at 3 months postpartum
Offspring birth weight, length and head circumference
大体时间:At delivery
As recorded by the hospital
At delivery
Delivery complications
大体时间:At delivery
Vaginal or caesarean delivery, and recorded complications during the delivery
At delivery
Markers of inflammation and metabolism in cord blood
大体时间:At delivery
Cord blood will be sampled and stored for later analysis of relevant markers of inflammation and metabolism (including resistin, leptin, adiponectin)
At delivery

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

一般刊物

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2010年9月1日

初级完成 (实际的)

2015年6月1日

研究完成 (实际的)

2016年6月1日

研究注册日期

首次提交

2010年9月6日

首先提交符合 QC 标准的

2010年11月17日

首次发布 (估计)

2010年11月18日

研究记录更新

最后更新发布 (实际的)

2020年1月28日

上次提交的符合 QC 标准的更新

2020年1月24日

最后验证

2018年6月1日

更多信息

与本研究相关的术语

其他相关的 MeSH 术语

其他研究编号

  • ETiP-Ob

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅